Nan Shan Life Insurance’s Eli Lilly LLY Stock Holding History

Nan Shan Life Insurance’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3M	Sell	10,214 -5,472	-35%	-$5.59M	0.38%	59
2026 Q1	$14.4M	Buy	+15,686	New	+$15.9M	0.52%	52
2025 Q4	–	Sell	-21,004	Closed	-$16M	–	93
2025 Q3	$16M	Sell	21,004 -15,693	-43%	-$11.7M	0.34%	70
2025 Q2	$28.6M	Buy	36,697 +25,571	+230%	+$19.9M	0.64%	54
2025 Q1	$9.19M	Sell	11,126 -4,840	-30%	-$4.03M	0.22%	82
2024 Q4	$12.3M	Buy	+15,966	New	+$13.2M	0.3%	78
2022 Q2	–	Sell	-120,174	Closed	-$34.4M	–	92
2022 Q1	$34.4M	Buy	120,174 +6,040	+5%	+$1.55M	0.6%	54
2021 Q4	$31.5M	Buy	114,134 +54,134	+90%	+$13.7M	0.48%	65
2021 Q3	$13.9M	Hold	60,000	–	–	0.23%	81
2021 Q2	$13.8M	Buy	60,000 +40,000	+200%	+$8.03M	0.23%	86
2021 Q1	$3.74M	Buy	+20,000	New	+$3.91M	0.07%	111

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nan Shan Life Insurance's LLY Position: Q2 2026 in Review

Nan Shan Life Insurance reduced its Eli Lilly (LLY) stake by 35% in Q2 2026, selling an estimated $5.59M and leaving 10,214 shares worth $12.3M. The position accounts for 0.38% of the portfolio, ranked #59.

Nan Shan Life Insurance first reported a position in LLY in Q1 2021 and has held it in 11 quarters since. The position peaked at $34.4M in Q1 2022. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Nan Shan Life Insurance held 10,214 shares of Eli Lilly worth $12.3M as of Q2 2026.
Nan Shan Life Insurance sold 5,472 Eli Lilly shares in Q2 2026, an estimated $5.59M.
Eli Lilly made up 0.38% of Nan Shan Life Insurance's portfolio in Q2 2026, its #59 holding.
Nan Shan Life Insurance first reported a position in Eli Lilly in Q1 2021 and has held it in 11 quarters since.
Nan Shan Life Insurance's Eli Lilly position peaked at $34.4M in Q1 2022.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nan Shan Life Insurance's 13F filing for Q2 2026, filed 14 Aug 2026.